Gastric Schwannoma Demonstrated on 18 F FDG PET/CT With Pathological Correlation

Jeffrey Chen1, Chuong Bui1, Han Loh1

  • 1From the Department of Nuclear Medicine and PET, Nepean Hospital, Kingswood.

Clinical Nuclear Medicine
|December 18, 2023
PubMed

Insights

A rare gastric schwannoma was diagnosed in a patient with epigastric pain. Imaging revealed a distinct mass with high FDG uptake, confirmed by pathology after surgery.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Diagnostic Imaging

Background:

  • A 66-year-old male with hypertension and type 2 diabetes presented with a month of epigastric pain.
  • Differential diagnoses for epigastric pain include various gastrointestinal pathologies.

Observation:

  • Abdominal CT and MRI revealed a round, homogeneously enhancing mass on the stomach's lesser curvature.
  • 18F-FDG PET/CT demonstrated significant hypermetabolism within the gastric mass, with a maximum standardized uptake value (SUV max) of 9.6.

Findings:

  • Surgical resection via partial gastrectomy was performed.
  • Pathological examination and immunohistochemical analysis confirmed the diagnosis of gastric schwannoma.

Implications:

  • This case highlights the importance of considering rare tumors in the differential diagnosis of gastric masses.
  • Advanced imaging techniques like PET/CT can aid in characterizing gastric lesions and assessing their metabolic activity.
  • Accurate diagnosis and surgical management are crucial for favorable outcomes in patients with gastric schwannoma.

Related Concept Videos